HIV/AIDS Therapy

Federal grant awarded for study of HIV drug targets

Published in AIDS Weekly, June 23rd, 2003

A federal research grant to study human genes as possible drug targets for fighting HIV (human immunodeficiency virus) infection has been awarded jointly to Virogenomics Inc., a Portland-based drug discovery company, and scientists at Oregon Health & Science University (OSHU).

"While modern antiretroviral drugs have enabled many HIV-positive individuals to live longer and delay progression of the disease to AIDS, these drugs do not ultimately cure infection," said Ashlee Moses, PhD, the study's principal investigator and assistant scientist at OHSU's Vaccine and Gene Therapy Institute (VGTI).

"Unlike research before it that has focused on HIV genes,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2003-06-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry